Werewolf Therapeutics (HOWL) Other Working Capital Changes (2020 - 2026)

Werewolf Therapeutics (HOWL) has reported Other Working Capital Changes for 7 consecutive years, with -$2.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Other Working Capital Changes fell 613.66% year-over-year to -$2.8 million in Q2 2026; TTM through Jun 2026 was -$4.0 million, a 171.06% decrease from a year earlier, with the FY2025 full-year figure at -$1.6 million, up 3.17% from the prior year.
• Other Working Capital Changes was -$2.8 million for Q2 2026 at Werewolf Therapeutics, down from -$615000.0 in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $13.1 million in Q2 2022 and troughed at -$3.1 million in Q4 2022.
• A 3-year average of $0.0 and a median of -$1.1 million in 2023 frame the typical range for Other Working Capital Changes.
• Across the five-year window, Other Working Capital Changes sank 2108.64% in 2022 and surged 91.84% in 2023, its largest moves.
• Over 5 years, Other Working Capital Changes stood at -$4.4 million in 2022, then surged by 91.84% to -$357000.0 in 2023, then jumped by 52.66% to -$169000.0 in 2024, then declined by 23.67% to -$209000.0 in 2025, then plunged by 1224.88% to -$2.8 million in 2026.
• The last three Other Working Capital Changes figures came in at -$2.8 million (Q2 2026), -$615000.0 (Q1 2026), and -$209000.0 (Q4 2025), per Business Quant data.